[Federal Register Volume 67, Number 89 (Wednesday, May 8, 2002)]
[Notices]
[Pages 30931-30932]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-11361]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

Food and Drug Administration

National Institutes of Health


A Public Health Action Plan To Combat Antimicrobial Resistance 
(Part I: Domestic Issues): Meeting for Public Comment on the 
Antimicrobial Resistance Interagency Task Force Annual Report

    The Centers for Disease Control and Prevention (CDC), Food and Drug 
Administration (FDA), and National Institutes of Health (NIH) announce 
an open meeting concerning antimicrobial resistance.
    Name: A Public Health Action Plan to Combat Antimicrobial 
Resistance (Part I: Domestic Issues): Meeting for Public Comment on the 
Antimicrobial Resistance Interagency Task Force Annual Report.
    Time and Date: 10 a.m.-5 p.m., June 26, 2002.
    Place: Holiday Inn Select, Versailles Ballroom, 8120 Wisconsin 
Avenue, Bethesda, Maryland, 20814. (Toll-Free: 1-877-888-3001; Tel: 1-
301-652-2000; Fax: 1-301-652-4525).
    Status: Open to the public, limited only by the space available.
    Purpose: To present the first annual report of progress by Federal 
agencies in accomplishing activities outlined in A Public Health Action 
Plan to Combat Antimicrobial Resistance (Part I: Domestic Issues) and 
solicit comments from the public regarding the annual report. The 
Action Plan serves as a blueprint for activities of Federal agencies to 
address antimicrobial resistance. The focus of the plan is on domestic 
issues.
    Matters To Be Discussed: The agenda will consist of welcome, 
introductory comments, followed by discussion of each focus area in 
sequential plenary sessions lasting about 75 minutes each. The four 
focus areas are: Surveillance, Prevention and Control, Research, and 
Product Development. Session leaders will give a 10 to 15 minute 
overview at the beginning of each session, then open the meeting for 
general discussion.
    Comments and suggestions from the public for Federal agencies 
related to each of the focus areas will be taken under advisement by 
the Antimicrobial Resistance Interagency Task Force. The agenda does 
not include development of consensus positions, guidelines, or 
discussions or endorsement of specific commercial products.
    The Action Plan, Annual Report, and meeting agenda are available at 
http://www.cdc.gov/drugresistance. The public meeting is sponsored by 
the CDC, FDA, and NIH in collaboration with seven other Federal 
agencies and departments involved in developing and writing A Public 
Health Action Plan to Combat Antimicrobial Resistance (Part I: Domestic 
Issues).
    Agenda items are subject to change as priorities dictate.
    Limited time will be available for oral questions, comments, and 
suggestions from the public. Depending on the number wishing to 
comment, a time limit of three minutes may be imposed. In the interest 
of time, visual aids will not be permitted, although written material 
may be submitted for subsequent review by the Task Force. Written 
comments and suggestions from the public are encouraged and should be 
received by the contact person or email listed below prior to the 
opening of the meeting or no later than the end of July 2002.

[[Page 30932]]

    Persons anticipating attending the meeting are requested to send 
written notification by June 22, 2002, including name, organization (if 
applicable), address, phone, fax, and e-mail address.

CONTACT PERSON FOR MORE INFORMATION: Vickie Garrett, Antimicrobial 
Resistance, Office of the Director, NCID, CDC, Mailstop C-12, 1600 
Clifton Road, NE, Atlanta, GA 30333; telephone 404-639-2603; fax 404-
639-4197; or e-mail [email protected].
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

    Dated: April 11, 2002.
Alvin Hall,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
    Dated: April 16, 2002.
Ruth L. Kirschstein,
Acting Director, National Institutes of Health.
    Dated: April 26, 2002.
Margaret M. Dotzel,
Associate Commissioner for Policy.
[FR Doc. 02-11361 Filed 5-7-02; 8:45 am]
BILLING CODE 4163-18-P